Partnership
The UK off-patent industry is a key part of an efficient supply chain which ensures patients access the medicines they need in a timely and affordable manner. As part of this, manufacturers liaise regularly with the government, regulators and commissioners to ensure product safety, quality and certainty of supply.
Engagement
Medicines UK works closely with a wide range of partners and stakeholders to promote awareness and understanding of the generic and biosimilar market in the UK and how it operates. As the sector which provides patients with the vast majority of medicines they require, we have regular interaction with government departments, policymakers and ministers to ensure the safe and sustainable running of the NHS.
We also liaise closely with NHS England, the MHRA and NICE on initiatives which drive uptake and promote access to affordable medicines.
Finally, we work with patient groups, think tanks, industry bodies, academia and the media, among others, to represent the interests of our sector.
International outreach
Where appropriate, we work closely with representative and relevant international bodies and organisations, liaising on issues such as regulation, IP, trade, manufacturing and supply.
As the UK broadens its free trade agreements with key international partners, it is important that issues such as medicines supply feature in those discussions.
With a globalised supply chain for medicines production, it is a matter of national security that engagement takes place with international partners who can support resilience.
Latest industry news
Partnership will revive inactive licences to solve critical medicines shortages
By Jeremy Durrant